Clarithromycin versus gemifloxacin in quadruple therapeutic regimens for helicobacter pylori infection eradication
Middle East Journal of Digestive Diseases. 2017; 9 (2): 100-106
in English
| IMEMR
| ID: emr-187583
ABSTRACT
Background:
helicobacter pylori [H. pylori] infection is a major casual factor in any peptic diseases. Clarithromycin as one of the drugs recommended for the infection eradication regimen has shown different levels of resistance. The present study is comparing the effectiveness of clarithromycin- and gemifloxacin - based quadruple regimens in H. pylori eradication
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Type of study:
Controlled clinical trial
Language:
English
Journal:
Middle East J. Dig. Dis.
Year:
2017
Similar
MEDLINE
...
LILACS
LIS